Suzuki Sayaka, Yasunaga Hideo, Matsui Hiroki, Fushimi Kiyohide, Saito Yuki, Yamasoba Tatsuya
From the Department of Otolaryngology, Head and Neck Surgery, Faculty of Medicine (SS, YS, TY) and Department of Clinical Epidemiology and Health Economics, School of Public Health (HY, HM), University of Tokyo; and Department of Health Policy and Informatics, Tokyo Medical and Dental University Graduate School of Medicine (KF), Tokyo, Japan.
Medicine (Baltimore). 2016 Feb;95(7):e2812. doi: 10.1097/MD.0000000000002812.
To identify risk factors for post-thyroidectomy hematoma requiring airway intervention or surgery ("wound hematoma") and determine post-thyroidectomy time to intervention. Post-thyroidectomy hematoma is rare but potentially lethal. Information on wound hematoma in a nationwide clinical setting is scarce.Using the Japanese Diagnosis Procedure Combination database, we extracted data from records of patients undergoing thyroidectomy from July 2010 to March 2014. Patients with clinical stage IV cancer or those with bilateral neck dissection were excluded because they could have undergone planned tracheotomy on the day of thyroidectomy. We assessed the association between background characteristics and wound hematoma ≤2 days post-thyroidectomy, using multivariable logistic regression analysis. Among 51,968 patients from 880 hospitals, wound hematoma occurred in 920 (1.8%) ≤2 days post-thyroidectomy and in 203 (0.4%) ≥3 days post-thyroidectomy (in-hospital mortality = 0.05%). Factors significantly associated with wound hematoma ≤2 days post-thyroidectomy were male sex (odds ratio [OR] 1.52, 95% confidence interval [CI] 1.30-1.77); higher age (OR 1.01, 95% CI 1.00-1.02); overweight or obese (OR 1.22, 95% CI 1.04-1.44); type of surgery (partial thyroidectomy for benign tumor compared with: total thyroidectomy, benign tumor [OR 1.95, 95% CI 1.45-2.63]; partial thyroidectomy, malignant tumor [OR 1.21, 95% CI 1.00-1.46]; total thyroidectomy, malignant tumor [OR 2.49, 95% CI 1.82-3.49]; and thyroidectomy for Graves disease [OR 3.88, 95% CI 2.59-5.82]); neck dissection (OR, 1.53, 95% CI 1.05-2.23); antithrombotic agents (OR 1.58, 95% CI 1.15-2.17); and blood transfusion (OR 5.33, 95% CI 2.39-11.91). Closer monitoring of airway and neck is recommended for patients with risk factors, and further cautious monitoring beyond 3 days post-thyroidectomy.
确定甲状腺切除术后需要气道干预或手术(“伤口血肿”)的危险因素,并确定甲状腺切除术后至干预的时间。甲状腺切除术后血肿虽罕见但可能致命。全国临床环境中关于伤口血肿的信息匮乏。
利用日本诊断程序组合数据库,我们从2010年7月至2014年3月接受甲状腺切除术的患者记录中提取数据。临床IV期癌症患者或双侧颈清扫患者被排除,因为他们可能在甲状腺切除当天接受了计划性气管切开术。我们使用多变量逻辑回归分析评估了背景特征与甲状腺切除术后≤2天伤口血肿之间的关联。
在来自880家医院的51968例患者中,920例(1.8%)在甲状腺切除术后≤2天出现伤口血肿,203例(0.4%)在甲状腺切除术后≥3天出现伤口血肿(院内死亡率=0.05%)。与甲状腺切除术后≤2天伤口血肿显著相关的因素包括男性(比值比[OR]1.52,95%置信区间[CI]1.30 - 1.77);年龄较大(OR 1.01,95% CI 1.00 - 1.02);超重或肥胖(OR 1.22,95% CI